Jensen, K P
Herman, A I
Morean, M E
Kranzler, H R
Gelernter, J
Sofuoglu, M
Article History
Received: 7 August 2014
Revised: 24 September 2014
Accepted: 5 November 2014
First Online: 23 December 2014
Competing interests
: Unrelated to this research, Dr Kranzler has been a consultant or advisory board member for Alkermes, Lilly, Lundbeck, Otsuka, Pfizer, and Roche. He is also a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which is supported by AbbVie, Ethypharm, Lilly, Lundbeck and Pfizer and has a US patent pending entitled, ‘Test for Predicting Response to Topiramate and Use of Topiramate’. Dr Sofuoglu has served as an expert witness on behalf of Pfizer in lawsuits related to varenicline. All other authors declare no potential conflict of interest.